Revvity Diagnostics revenue
Diagnostics revenue at Revvity came to $349.3M for the quarter to 4 Oct 2026, down 1.9% from a year earlier.
As Revvity reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 10 Nov 2026.
By quarter
| Period ending | Diagnostics revenue | Change on a year | Filed |
|---|---|---|---|
| 4 Oct 2026 | $349.3M | down 1.9% | 10 Nov 2026 |
| 5 Jul 2026 | $371.0M | up 4.7% | 11 Aug 2026 |
| 5 Apr 2026 | $349.3M | up 7.7% | 12 May 2026 |
| 28 Dec 2025 | $390.1M | — | 24 Feb 2026 |
| 28 Sep 2025 | $356.1M | — | 4 Nov 2025 |
| 29 Jun 2025 | $354.4M | — | 5 Aug 2025 |
| 30 Mar 2025 | $324.4M | — | 6 May 2025 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Revvity: Reconciliati on of financial organic revenue growth from continuing operations (change on a year) · Product revenue · Service revenue · Life Sciences revenue · United States revenue · China revenue · Americas revenue · Europe revenue · Germany revenue · Asia revenue · United Kingdom revenue · financial statements
Every KPI and segment of RVTY, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.